STOCK TITAN

The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

The Oncology Institute (NASDAQ: TOI) has announced that its executives will participate in multiple panel presentations at the APG 2024 Spring Conference in San Diego. Dr. Yale Podnos, Chief Medical Officer, will discuss the use of artificial intelligence in oncology practices during the breakout session titled 'AI on the Front Lines: Improving Outcomes and Reducing Costs for Complex Patients'. Additionally, CEO Dr. Daniel Virnich will join a panel discussing global risk management in pharmaceuticals. The event takes place in May 2024 and highlights the institute's focus on integrating advanced technology and risk management strategies in oncology.

Positive
  • Executive participation in prominent industry event.
  • Focus on integrating artificial intelligence in oncology to improve outcomes and reduce costs.
  • CEO involvement in discussions on global risk management for pharmaceuticals.
Negative
  • No immediate financial data or performance metrics provided.
  • Potential investor uncertainty due to lack of concrete business outcomes from the conference.

CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives’ participation in multiple panel presentations at the upcoming APG 2024 Spring Conference in San Diego. Chief Medical Officer, Dr. Yale Podnos, will be discussing artificial intelligence and its uses in an oncology practice in the breakout session panel “AI on the Front Lines: Improving Outcomes and Reducing Costs for Complex Patients”. Dr. Daniel Virnich, Chief Executive Officer, will join other industry leaders on another panel, “Assuming Global Risk for Pharmaceuticals.”

About The Oncology Institute

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Contacts

Investors at Solebury Strategic Communications

investors@theoncologyinstitute.com


FAQ

What is the Oncology Institute's stock symbol?

The stock symbol for the Oncology Institute is TOI.

When is the APG 2024 Spring Conference?

The APG 2024 Spring Conference will take place in May 2024.

Who will represent the Oncology Institute at the APG 2024 Spring Conference?

Dr. Yale Podnos and Dr. Daniel Virnich will represent the Oncology Institute at the conference.

What topics will be covered by the Oncology Institute at the APG 2024 Spring Conference?

The topics include the use of artificial intelligence in oncology and global risk management in pharmaceuticals.

The Oncology Institute, Inc.

NASDAQ:TOI

TOI Rankings

TOI Latest News

TOI Stock Data

21.14M
75.49M
19.56%
45.35%
0.33%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
CERRITOS